Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT00531453. IPD Sharing: Not stated. Countries: 1. Publications: 2.
PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03269136. IPD Sharing: NO. Countries: 2. Publications: 3.
A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03277105. IPD Sharing: Not stated. Countries: 18. Publications: 6.
Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT00478218. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT04151667. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT00689936. IPD Sharing: Not stated. Countries: 19. Publications: 13.
Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00483262. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01496118. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04649060. IPD Sharing: NO. Countries: 11. Publications: 2.
MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00833833. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma
ClinicalTrials.gov study NCT01677858. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT01248455. IPD Sharing: NO. Countries: 1. Publications: 4.
Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma
ClinicalTrials.gov study NCT00813150. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00461045. IPD Sharing: YES. Countries: 1. Publications: 28.
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT02316106. IPD Sharing: Not stated. Countries: 11. Publications: 3.
Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma
ClinicalTrials.gov study NCT00049673. IPD Sharing: NO. Countries: 1. Publications: 2.
Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
ClinicalTrials.gov study NCT01239368. IPD Sharing: NO. Countries: 1. Publications: 3.
Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Tran
ClinicalTrials.gov study NCT02513186. IPD Sharing: YES. Countries: 4. Publications: 1.
S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
ClinicalTrials.gov study NCT01668719. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma
ClinicalTrials.gov study NCT03224507. IPD Sharing: NO. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.